GLAND PHARMA
|
GLAND PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹5,665 Cr | ₹3,625 Cr | ₹4,401 Cr | ₹3,463 Cr | ₹2,633 Cr |
Sales | ₹4,078 Cr | ₹3,272 Cr | ₹3,970 Cr | ₹3,131 Cr | ₹2,322 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹1,564 Cr | ₹319 Cr | ₹414 Cr | ₹292 Cr | ₹250 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹23 Cr | ₹33 Cr | ₹17 Cr | ₹39 Cr | ₹61 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹5,665 Cr | ₹3,625 Cr | ₹4,401 Cr | ₹3,463 Cr | ₹2,633 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹128 Cr | ₹-47 Cr | ₹37 Cr | ₹-273 Cr | ₹-6.90 Cr |
Raw Material Consumed | ₹2,045 Cr | ₹1,732 Cr | ₹2,073 Cr | ₹1,492 Cr | ₹843 Cr |
Opening Raw Materials | ₹979 Cr | ₹466 Cr | ₹530 Cr | ₹302 Cr | ₹428 Cr |
Purchases Raw Materials | ₹1,502 Cr | ₹2,230 Cr | ₹1,983 Cr | ₹1,704 Cr | ₹699 Cr |
Closing Raw Materials | ₹459 Cr | ₹979 Cr | ₹466 Cr | ₹530 Cr | ₹302 Cr |
Other Direct Purchases / Brought in cost | ₹23 Cr | ₹16 Cr | ₹26 Cr | ₹16 Cr | ₹19 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹230 Cr | ₹125 Cr | ₹95 Cr | ₹75 Cr | ₹79 Cr |
Electricity & Power | ₹230 Cr | ₹125 Cr | ₹95 Cr | ₹75 Cr | ₹79 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1,257 Cr | ₹403 Cr | ₹339 Cr | ₹311 Cr | ₹278 Cr |
Salaries, Wages & Bonus | ₹955 Cr | ₹363 Cr | ₹300 Cr | ₹260 Cr | ₹238 Cr |
Contributions to EPF & Pension Funds | ₹252 Cr | ₹16 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr |
Workmen and Staff Welfare Expenses | ₹40 Cr | ₹18 Cr | ₹15 Cr | ₹20 Cr | ₹8.91 Cr |
Other Employees Cost | ₹10 Cr | ₹6.70 Cr | ₹11 Cr | ₹21 Cr | ₹20 Cr |
Other Manufacturing Expenses | ₹327 Cr | ₹194 Cr | ₹180 Cr | ₹437 Cr | ₹392 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹151 Cr | ₹49 Cr | ₹45 Cr | ₹42 Cr | ₹34 Cr |
Packing Material Consumed | - | - | - | ₹273 Cr | ₹266 Cr |
Other Mfg Exp | ₹176 Cr | ₹145 Cr | ₹135 Cr | ₹122 Cr | ₹92 Cr |
General and Administration Expenses | ₹217 Cr | ₹121 Cr | ₹94 Cr | ₹59 Cr | ₹58 Cr |
Rent , Rates & Taxes | ₹71 Cr | ₹65 Cr | ₹59 Cr | ₹38 Cr | ₹38 Cr |
Insurance | ₹29 Cr | ₹11 Cr | ₹9.88 Cr | ₹6.37 Cr | ₹2.93 Cr |
Printing and stationery | ₹4.09 Cr | ₹3.15 Cr | ₹3.29 Cr | ₹2.90 Cr | ₹2.45 Cr |
Professional and legal fees | ₹94 Cr | ₹36 Cr | ₹19 Cr | ₹7.87 Cr | ₹9.12 Cr |
Traveling and conveyance | ₹9.57 Cr | ₹3.85 Cr | ₹1.84 Cr | ₹1.39 Cr | ₹3.11 Cr |
Other Administration | ₹9.10 Cr | ₹1.32 Cr | ₹1.28 Cr | ₹2.23 Cr | ₹2.27 Cr |
Selling and Distribution Expenses | ₹37 Cr | ₹27 Cr | ₹41 Cr | ₹37 Cr | ₹17 Cr |
Advertisement & Sales Promotion | ₹4.61 Cr | ₹4.56 Cr | ₹2.02 Cr | ₹1.95 Cr | ₹5.19 Cr |
Sales Commissions & Incentives | ₹14 Cr | ₹2.76 Cr | ₹3.88 Cr | ₹1.77 Cr | ₹1.45 Cr |
Freight and Forwarding | ₹19 Cr | ₹20 Cr | ₹35 Cr | ₹33 Cr | ₹10 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹90 Cr | ₹45 Cr | ₹33 Cr | ₹24 Cr | ₹19 Cr |
Bad debts /advances written off | ₹7.59 Cr | ₹2.20 Cr | ₹0.34 Cr | ₹0.28 Cr | ₹1.62 Cr |
Provision for doubtful debts | ₹14 Cr | - | ₹3.79 Cr | ₹0.12 Cr | ₹4.32 Cr |
Losson disposal of fixed assets(net) | - | ₹0.08 Cr | ₹0.18 Cr | - | - |
Losson foreign exchange fluctuations | - | - | - | - | - |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹68 Cr | ₹42 Cr | ₹28 Cr | ₹23 Cr | ₹13 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹4,332 Cr | ₹2,600 Cr | ₹2,891 Cr | ₹2,161 Cr | ₹1,678 Cr |
Operating Profit (Excl OI) | ₹1,333 Cr | ₹1,025 Cr | ₹1,510 Cr | ₹1,302 Cr | ₹955 Cr |
Other Income | ₹170 Cr | ₹240 Cr | ₹224 Cr | ₹135 Cr | ₹139 Cr |
Interest Received | ₹151 Cr | ₹179 Cr | ₹139 Cr | ₹86 Cr | ₹51 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹0.25 Cr | - | - | ₹0.02 Cr | ₹17 Cr |
Profits on sale of Investments | ₹0.35 Cr | ₹2.85 Cr | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹11 Cr | ₹57 Cr | ₹79 Cr | ₹41 Cr | ₹69 Cr |
Others | ₹8.43 Cr | ₹1.05 Cr | ₹6.09 Cr | ₹8.28 Cr | ₹0.98 Cr |
Operating Profit | ₹1,503 Cr | ₹1,265 Cr | ₹1,734 Cr | ₹1,437 Cr | ₹1,095 Cr |
Interest | ₹26 Cr | ₹7.45 Cr | ₹5.24 Cr | ₹3.41 Cr | ₹7.18 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹4.41 Cr | ₹1.16 Cr | ₹1.84 Cr | ₹0.50 Cr | ₹0.93 Cr |
Other Interest | ₹22 Cr | ₹6.29 Cr | ₹3.40 Cr | ₹2.91 Cr | ₹6.25 Cr |
PBDT | ₹1,477 Cr | ₹1,258 Cr | ₹1,729 Cr | ₹1,434 Cr | ₹1,087 Cr |
Depreciation | ₹345 Cr | ₹147 Cr | ₹110 Cr | ₹99 Cr | ₹95 Cr |
Profit Before Taxation & Exceptional Items | ₹1,133 Cr | ₹1,111 Cr | ₹1,619 Cr | ₹1,335 Cr | ₹993 Cr |
Exceptional Income / Expenses | - | ₹-56 Cr | - | - | - |
Profit Before Tax | ₹1,133 Cr | ₹1,055 Cr | ₹1,619 Cr | ₹1,335 Cr | ₹993 Cr |
Provision for Tax | ₹360 Cr | ₹274 Cr | ₹407 Cr | ₹338 Cr | ₹220 Cr |
Current Income Tax | ₹349 Cr | ₹277 Cr | ₹396 Cr | ₹339 Cr | ₹251 Cr |
Deferred Tax | ₹14 Cr | ₹-2.80 Cr | ₹14 Cr | ₹0.12 Cr | ₹-32 Cr |
Other taxes | ₹-3.55 Cr | ₹-0.82 Cr | ₹-3.00 Cr | ₹-1.72 Cr | ₹0.43 Cr |
Profit After Tax | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr | ₹773 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | - |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr | ₹773 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr | ₹3,026 Cr | ₹2,253 Cr |
Appropriations | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr | ₹3,026 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | - | - | - | - | - |
Equity Dividend % | ₹2,000.00 | - | - | - | - |
Earnings Per Share | ₹46.90 | ₹47.42 | ₹73.75 | ₹60.94 | ₹49.88 |
Adjusted EPS | ₹46.90 | ₹47.42 | ₹73.75 | ₹60.94 | ₹49.88 |
Compare Income Statement of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹30,794.5 Cr | 0.2% | -4.4% | 0.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,191.0 Cr | 1% | -0.9% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,973.0 Cr | -1.6% | -1.8% | 17.9% | Stock Analytics | |
CIPLA | ₹124,507.0 Cr | -1.8% | 3.7% | -6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,175.0 Cr | 0.7% | 2.4% | 3.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,355.0 Cr | -0.6% | 4.5% | -6.5% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 0.2% |
-4.4% |
0.3% |
SENSEX | 0.5% |
0.1% |
-2.1% |
You may also like the below Video Courses